The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.30
Bid: 17.60
Ask: 17.70
Change: 0.00 (0.00%)
Spread: 0.10 (0.568%)
Open: 17.30
High: 0.00
Low: 0.00
Prev. Close: 17.30
CPIC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

1 Jul 2020 07:00

RNS Number : 6143R
UBS AG London Branch
01 July 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

01 July 2020

 

China Pacific Insurance (Group) Co., LTD.

Mid-stabilisation Period Notice 

 

Further to the pre-stabilisation period announcement dated 16 June 2020, UBS AG London Branch (Contact: Francois-Olivier Mercier, Syndicate Desk: +44 20756 87504) hereby gives notice that stabilisation (within the meaning of Commission Delegated Regulation (EU) 2016/1052 supplementing the Market Abuse Regulation (EU) 596/2014) in relation to the offer of the following securities undertook by it or any of its affiliates in accordance with the rules of the Financial Conduct Authority.

 

The securities:

Issuer:

China Pacific Insurance (Group) Co., LTD.

Securities:

Global Depositary Receipts ("GDRs") each representing 5 A shares of the Company

ISIN:

US16951T1198

Offering size:

Institutional Offering: 102,873,300 GDRs (excluding the over-allotment option)

Market:

London Stock Exchange plc, Shanghai-London Stock Connect segment

Ticker:

CPIC

Description:

Initial Public Offering of GDRs

Offer price:

US$ 17.60 per GDR

Associated securities:

There are no associated instruments that are subject to stabilisation

Stabilising Manager:

UBS AG London Branch, 5 Broadgate, London. EC2M 2QS 

 

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

 

Trade Date

Lowest price (US$)

Highest price (US$)

Trading Venue

29/06/2020

17.60

17.60

LSE

 

 

Important legal information

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, Japan, South Africa or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer to sell, or solicitation of an offer to buy, acquire or subscribe for any securities to any person in the United States (including its territories and possessions, any state of the United States and the District of Columbia) or in any other jurisdiction in which such offer or solicitation would be unlawful. The GDRs have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any State or other jurisdiction of the United States and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to or an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any applicable state or local securities law. The Company has not intended and does not intend to make any public offer of securities in the United States. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the Company and that will contain detailed information about the Company and management, as well as financial statements.

In any member state of the European Economic Area (the "EEA") (each, a "Relevant Member State"), this announcement and the Offering are only addressed to and directed at persons who are "qualified investors" ("Qualified Investors") within the meaning of the Regulation (EU) 2017/1129 (the "Prospectus Regulation").

In the United Kingdom, this announcement and any offer if made subsequently is only addressed to and directed at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), (ii) high net worth entities who fall within Article 49(2)(a) to (d) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons being referred to as "relevant persons"). This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not relevant persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to and will only be engaged with (i) in the United Kingdom, relevant persons, and (ii) in any member state of the EEA, Qualified Investors and other persons who are permitted to subscribe for the GDRs described herein pursuant to an exemption from the Prospectus Regulation and other applicable legislation, and will only be engaged in with such persons.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAFMMRTMTJJBLM
Date   Source Headline
26th May 202311:54 amRNSAnnouncement on Poll Results for the 2022 AGM
12th May 20239:53 amRNSAnnouncement relating to Premium Income
27th Apr 20231:10 pmRNS2023 First Quarter Report
27th Apr 202312:58 pmRNSPublication of Summaries of Solvency Reports
21st Apr 20232:23 pmRNS2022 Sustainability Report
21st Apr 20232:03 pmRNSNotice of the 2022 AGM
17th Apr 202311:59 amRNSAnnouncement relating to Premium Income
27th Mar 20237:00 amRNSPublication of 2022 Annual Results Presentation
27th Mar 20237:00 amRNSPublication of Summaries of Solvency Reports
27th Mar 20237:00 amRNSAnnual Financial Report
24th Mar 20232:15 pmRNSResignation of Director
16th Mar 202311:11 amRNSConvening of 2022 Annual Results Presentation
15th Mar 20239:00 amRNSAnnouncement relating to Premium Income
17th Feb 20239:35 amRNSAnnouncement relating to Premium Income
17th Jan 20239:30 amRNSAnnouncement relating to Premium Income
6th Jan 20239:52 amRNSRemuneration of Part of PDMR
14th Dec 20228:56 amRNSAnnouncement relating to Premium Income
23rd Nov 20224:56 pmRNSFollow-up Anncmnt on Q3 Investor Events
16th Nov 202210:28 amRNS2022 Q3 RESULTS PRESENTATION AND 2022 INVESTOR DAY
16th Nov 202210:11 amRNSAnnouncement relating to Premium Income
28th Oct 202212:18 pmRNSSummaries of Quarterly Solvency Reports
28th Oct 202212:07 pmRNS2022 Third Quarter Report
18th Oct 20229:17 amRNSAnnouncement relating to Premium Income
15th Sep 202210:01 amRNSAnnouncement relating to Premium Income
7th Sep 20229:48 amRNSResignation of Director
30th Aug 20227:00 amRNS2022 Interim Results Presentation Materials
30th Aug 20227:00 amRNSPublication of Summaries of Solvency Reports
30th Aug 20227:00 amRNSCPIC 2022 Interim Report
18th Aug 202212:22 pmRNSAnnouncement re 2022 Interim Results Presentation
12th Aug 202210:05 amRNSAnnouncement relating to Premium Income
11th Aug 20223:52 pmRNSApproval of Articles of Association by CBIRC
27th Jul 20224:47 pmRNSPDMR Shareholding
15th Jul 202211:11 amRNSAnnouncement relating to Premium Income
10th Jun 20221:50 pmRNSAnnouncement relating to Premium Income
8th Jun 20224:01 pmRNSPDMR Shareholding
8th Jun 20223:58 pmRNSPDMR Shareholding
8th Jun 20223:55 pmRNSDirector Shareholding
8th Jun 20223:52 pmRNSPDMR Shareholding
8th Jun 20223:46 pmRNSPDMR Shareholding
8th Jun 20223:42 pmRNS2021 AGM Poll Results
6th Jun 20227:00 amRNSPDMR Shareholding
6th Jun 20227:00 amRNSDirector Shareholding
30th May 20224:37 pmRNSDirector Shareholding
24th May 20225:43 pmRNSDirector Shareholding
24th May 20225:41 pmRNSDirector Shareholding
24th May 20225:37 pmRNSDirector Shareholding
24th May 20225:34 pmRNSDirector Shareholding
16th May 202210:21 amRNSAnnouncement relating to Premium Income
28th Apr 20224:21 pmRNSPublication of Summaries of Solvency Reports
28th Apr 20224:18 pmRNS2022 First Quarter Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.